The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activity of AT13387, a novel, non-ansamycin inhibitor of heat shock protein 90, against gastrointestinal stromal tumors (GIST).
Daruka Mahadevan
No relevant relationships to disclose
Geoffrey Shapiro
No relevant relationships to disclose
Sandra E. Kurtin
No relevant relationships to disclose
James M. Cleary
No relevant relationships to disclose
John F. Lyons
No relevant relationships to disclose
Ana Rodriguez-Lopez
No relevant relationships to disclose
Murray Yule
No relevant relationships to disclose
Valarie Ahanonu
No relevant relationships to disclose
Gavin S. Choy
No relevant relationships to disclose
Mojtaba Noursalehi
No relevant relationships to disclose
Mohammad Azab
No relevant relationships to disclose